Scott Rocklage is a managing partner at 5AM ventures and has been so since 2004. With over 30 years of experience working with healthcare management, his hard work has to led to the approval of the U.S. drugs Cubicin®, Omniscan™, and Teslascan®.
He received his Bachelor’s of Science degree in chemistry while attending the University of California, Berkley and went on, afterwards, to earn his Ph.D. in chemistry from MIT. While there, he took part in research in Nobel Prize Richard R. Schrock’s laboratory and, since, has written over 100 peer-reviewed publications. Read more: Scott Racklage | Bloomberg
Before the present time, Scott Rocklage worked in the Research and Developments arms of Salutar and Catalytica and was also the CEO and President of Nycomed Salutar.
He was also the CEO as well as a Chairman for Cubist Pharmaceuticals and sat as a Board Chairman for Novira and Relypsa. Currently, Scott is a Board Chairman of Kinestral and Cidara, Rennovia, Pulmatrix, and Epirus and has an office in Boston, MA.
A Deeper Look Into The Man Who Is Scott Rocklage
Scott Rocklage has had to overcome quite a bit to become the accomplished man he is today. He admits that many of his challenges have come from hiring the wrong people for the job, and he believes that the best thing someone can do in this situation is to move on as fast as possible.
The reason for this is that, in his experience, people’s underlying performance abilities won’t change because of performance goals and reviews that are set. He also holds to the idea that it is best for any business to stick with what it does best; even when it appears that expanding into other areas can be easy.
Some Of Scott’s Best Advice
Scott Rocklage advises people to go into business for themselves as an entrepreneur and believes that people should take measured risks in their career.
He recommends the book “Good to Great” for anyone who is looking to better understand business and performance and, to this day, helps entrepreneurs in their earliest stages of development to find the success they are seeking.